NEW YORK (GenomeWeb News) - Bristol-Myers Squibb has licensed GeneGo’s software and database platforms for its pharmaceutical research programs, GeneGo said today.
Under the multi-year agreement, BMS will use "all major GeneGo products" for chemical and biological studies, GeneGo said. BMS researchers will use the company’s tools to analyze data and to build their own pathway maps using public, GeneGo, and proprietary data.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.